Alicia Okines Selected Research

Alicia Okines Research Topics

Disease

12	Neoplasms (Cancer) 05/2024 - 08/2008
9	Breast Neoplasms (Breast Cancer) 05/2024 - 04/2011
4	Triple Negative Breast Neoplasms 04/2024 - 07/2023
4	Adenocarcinoma 01/2021 - 04/2010
3	Brain Neoplasms (Brain Tumor) 10/2020 - 01/2018
3	Stomach Neoplasms (Stomach Cancer) 09/2017 - 11/2007
2	Disease Progression 01/2022 - 01/2020
2	COVID-19 12/2021 - 01/2020
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 09/2023
1	Left Ventricular Dysfunction 11/2022
1	Myocarditis (Carditis) 11/2022
1	Lobular Carcinoma 04/2022
1	Nausea 01/2020
1	Fatigue 01/2020
1	Diarrhea 01/2020
1	Vomiting 01/2020
1	Infections 01/2020
1	Brain Diseases (Brain Disorder) 01/2018
1	Turcot syndrome 09/2017
1	Microsatellite Instability 09/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Neutropenia 01/2017
1	Ovarian Neoplasms (Ovarian Cancer) 12/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2010
1	Hypertension (High Blood Pressure) 09/2009
1	Intestinal Perforation 09/2009
1	Colorectal Neoplasms (Colorectal Cancer) 09/2009
1	Venous Thrombosis (Deep-Vein Thrombosis) 09/2009

Drug/Important Bio-Agent (IBA)

6	Capecitabine (Xeloda)FDA Link 10/2020 - 11/2007
5	Trastuzumab (Herceptin)FDA Link 09/2023 - 04/2011
5	Fluorouracil (Carac)FDA LinkGeneric 09/2017 - 11/2007
3	tucatinibIBA 09/2023 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 07/2023 - 01/2021
3	Ado-Trastuzumab EmtansineIBA 01/2020 - 01/2018
3	Cisplatin (Platino)FDA LinkGeneric 09/2017 - 04/2011
2	Estrogen ReceptorsIBA 05/2024 - 07/2023
2	sacituzumab govitecanIBA 04/2024 - 07/2023
2	ErbB Receptors (EGF Receptor)IBA 09/2023 - 01/2021
2	Neutralizing AntibodiesIBA 12/2021 - 12/2021
2	VaccinesIBA 12/2021 - 12/2021
2	Panitumumab (Vectibix)FDA Link 01/2021 - 04/2011
2	human ERBB2 proteinIBA 10/2020 - 01/2020
2	Lapatinib (GW572016)FDA Link 01/2018 - 04/2011
2	Epirubicin (Ellence)FDA LinkGeneric 09/2017 - 01/2017
1	Circulating Tumor DNAIBA 12/2023
1	Immunoconjugates (Immunoconjugate)IBA 07/2023
1	Immune Checkpoint InhibitorsIBA 11/2022
1	SteroidsIBA 11/2022
1	TroponinIBA 11/2022
1	Cell Adhesion MoleculesIBA 04/2022
1	Cadherins (E-Cadherin)IBA 04/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	N 30IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 12/2021
1	pertuzumabIBA 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 09/2017
1	PlatinumIBA 12/2015
1	SodiumIBA 03/2015
1	Monoclonal AntibodiesIBA 04/2011
1	Cetuximab (Erbitux)FDA Link 04/2011
1	Tyrosine Kinase InhibitorsIBA 04/2011
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2009
1	Bevacizumab (Avastin)FDA Link 09/2009
1	Angiogenesis InhibitorsIBA 09/2009
1	Leucovorin (Folinic Acid)FDA Link 09/2009
1	Platinum Compounds (Compounds, Platinum)IBA 08/2008
1	taxaneIBA 08/2008
1	AnthracyclinesIBA 08/2008

Therapy/Procedure

9	Therapeutics 01/2024 - 03/2015
8	Drug Therapy (Chemotherapy) 07/2023 - 11/2007
4	Neoadjuvant Therapy 05/2024 - 04/2010
2	Radiotherapy 01/2022 - 01/2018
2	Combination Drug Therapy (Combination Chemotherapy) 08/2008 - 11/2007
1	Immunotherapy 07/2023